Common antidepressant may ease long COVID’s crushing fatigue
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
The Source
SD
Science
Scientists detect hidden skin damage before it becomes visible
SD·9h ago·3 min read
Science
Alzheimer’s breakthrough: Scientists restore two hours of sleep without clearing brain plaques
SD·13h ago·3 min read
Science
Scientists discover a protein that protects the brain from Alzheimer’s damage
SD·17h ago·3 min read
Science
Scientists found two powerful new ways to destroy forever chemicals
SD·20h ago·3 min read
Related
On this beat
Science
The 1st ‘Avengers: Doomsday’ trailer is here, and it’s stuffed to bursting with superheroes
SPACE·2h ago·3 min read
Science
SpaceX targets July 23 for crucial Starship Flight 13 test launch after abort
SPACE·2h ago·3 min read
Science
Cyclospriasis cases climb; probe into Taylor Farms produce continues after false positive
LAT·2h ago·3 min read
Science
Scientists discover mystery molecule on Pluto and Saturn’s moon Titan: ‘We cannot say what it is’
SPACE·3h ago·3 min read